ResearcherFifth Affiliated Hospital of Xinjiang Medical UniversityActive in the last 2 years
Xinjian Xu
Matched on ORCID iD 0000-0002-5138-5719; OpenAlex author ID A5102862469.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- Efficacy and safety of the S-1, nab-paclitaxel, and gemcitabine triplet regimen in patients with resected pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fonc.2025.1622215↗
- [Factors influencing survival of patients with pancreatic adenocarcinoma after surgical resection]. Co-author DOI 10.3760/cma.j.issn.0376-2491.2018.08.011↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Donghui Ran · 1 shared paper, 2025
- Le-Ping Fang · 1 shared paper, 2018
- Pei-Yu Huang · 1 shared paper, 2018
- Yuan Ji Ma · 1 shared paper, 2018
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.